Lupin to approach USFDA for reinspection of key plants in next few months
Reportedly, regulatory action by the USFDA has impacted several new approvals, thus affecting the company's business in various…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Regular dose of aspirin can lower risk of inherited bowel cancer: Study
The research carried out by Universities of Newcastle and Leeds, and funded by Cancer Research UK, NIHR, Bayer Pharma AG and the…
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of…
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…
Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer…
Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with…
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Lupin ties up with Omron Healthcare
To strengthen respiratory disease management facilities
Medical device maker Omron Healthcare India has joined hands with…
Naari completes acquisition of ANDAs from Intas Pharmaceuticals
The portfolio acquired comprises eight US FDA approved ANDAs and two products pending approval
Naari Pharma has entered…
FDA approves drug to treat infants and children with HIV
The safety and effectiveness of Tivicay and Tivicay PD were supported by a trial that included 75 HIV-1–infected infants, children…
Sun Pharma presents insights into clinical use of ILUMYA in moderate-to-severe plaque psoriasis
Reportedly, updated cost analysis reveals ILUMYA is among the most cost-effective first-line treatments for moderate-to-severe…
Zydus Cadila inks licensing pact with Gilead for remdesivir
The licence is royalty-free until another pharma product or vaccine is approved for the treatment or prevention of COVID-19 by the…
Why should India adopt IoT for the pharma supply chain?
Karen Ravindranath, Director, WebNMS - The IoT division of Zoho Corp. outlines how IoT implementation can help ramp up efficiency,…
Lupin voluntarily recalls a lot of diabetes drug in the US
An FDA analysis showed that this lot exceeded the acceptable daily intake limit for NDMA, an impurity that can cause cancer
Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP
It is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of…
Remdesivir in India: An unfolding story
Remdesivir has emerged as one of the most promising drug candidates for the treatment of COVID-19. But, is it affordable for…
Dr Reddy’s announces launch of Colchicine Tablets USP in the US
It is available in 0.6 mg tablets in bottle count sizes of 30s and 100s
Gujarat FDCA collects 362 hand sanitiser samples for quality check
Of the 60-70 samples analysed so far, 14 have failed to meet the required quality requirements
US FDA grants approval of Uplizna to Viela Bio
Uplizna is the second FDA approved therapy for Neuromyelitis Optica Spectrum Disorder which offers patients additional treatment…